🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
BioNTech SE (VIE:BNTX)
Austria flag Austria · Delayed Price · Currency is EUR
73.70
-1.35 (-1.80%)
At close: Nov 20, 2026

BioNTech SE Statistics

Total Valuation

BioNTech SE has a market cap or net worth of EUR 18.28 billion. The enterprise value is 4.49 billion.

Market Cap18.28B
Enterprise Value 4.49B

Important Dates

The last earnings date was Tuesday, November 3, 2026.

Earnings Date Nov 3, 2026
Ex-Dividend Date n/a

Share Statistics

Current Share Class n/a
Shares Outstanding n/a
Shares Change (YoY) +4.29%
Shares Change (QoQ) -0.23%
Owned by Insiders (%) 16.22%
Owned by Institutions (%) 21.00%
Float 106.00M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 7.55
PB Ratio 1.03
P/TBV Ratio 1.13
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 1.79
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 8.55, with a Debt / Equity ratio of 0.02.

Current Ratio 8.55
Quick Ratio 7.91
Debt / Equity 0.02
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -92.55

Financial Efficiency

Return on equity (ROE) is -8.14% and return on invested capital (ROIC) is -29.88%.

Return on Equity (ROE) -8.14%
Return on Assets (ROA) -7.10%
Return on Invested Capital (ROIC) -29.88%
Return on Capital Employed (ROCE) -7.32%
Weighted Average Cost of Capital (WACC) n/a
Revenue Per Employee 310,017
Profits Per Employee -188,702
Employee Count7,807
Asset Turnover 0.12
Inventory Turnover 3.88

Taxes

In the past 12 months, BioNTech SE has paid 41.00 million in taxes.

Income Tax 41.00M
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -16.53% in the last 52 weeks.

Beta (5Y) n/a
52-Week Price Change -16.53%
50-Day Moving Average 81.71
200-Day Moving Average 83.84
Relative Strength Index (RSI) 32.52
Average Volume (20 Days) 154

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) 2.02

Income Statement

In the last 12 months, BioNTech SE had revenue of EUR 2.42 billion and -1.47 billion in losses. Loss per share was -6.09.

Revenue2.42B
Gross Profit 1.86B
Operating Income -1.34B
Pretax Income -1.43B
Net Income -1.47B
EBITDA -1.02B
EBIT -1.34B
Loss Per Share -6.09
Full Income Statement

Balance Sheet

The company has 13.70 billion in cash and 359.80 million in debt, with a net cash position of 13.34 billion.

Cash & Cash Equivalents 13.70B
Total Debt 359.80M
Net Cash 13.34B
Net Cash Per Share n/a
Equity (Book Value) 17.71B
Book Value Per Share 71.44
Working Capital 13.84B
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -230.80 million and capital expenditures -208.20 million, giving a free cash flow of -439.00 million.

Operating Cash Flow -230.80M
Capital Expenditures -208.20M
Depreciation & Amortization 325.70M
Net Borrowing 76.50M
Free Cash Flow -439.00M
FCF Per Share n/a
Full Cash Flow Statement

Margins

Gross margin is 76.73%, with operating and profit margins of -55.45% and -60.87%.

Gross Margin 76.73%
Operating Margin -55.45%
Pretax Margin -59.17%
Profit Margin -60.87%
EBITDA Margin -41.99%
EBIT Margin -55.45%
FCF Margin n/a

Dividends & Yields

BioNTech SE does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
FCF Payout Ratio n/a
Buyback Yield -4.29%
Shareholder Yield -4.29%
Earnings Yield -8.27%
FCF Yield -2.40%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a
Graham Formula Value n/a
Graham Formula Upside n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

BioNTech SE has an Altman Z-Score of 7.02 and a Piotroski F-Score of 2.

Altman Z-Score 7.02
Piotroski F-Score 2